Stifel Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$123K Sell
34,356
-644
-2% -$2.56K ﹤0.01% 3516
2025
Q4
$123K Sell
35,000
-4,200
-11% -$14.4K ﹤0.01% 3462
2025
Q3
$128K Buy
39,200
+22,850
+140% +$72K ﹤0.01% 3419
2025
Q2
$40.1K Sell
16,350
-2,656
-14% -$13.5K ﹤0.01% 3426
2025
Q1
$127K Sell
19,006
-1,457
-7% -$14.4K ﹤0.01% 3266
2024
Q4
$257K Buy
20,463
+370
+2% +$5.57K ﹤0.01% 3040
2024
Q3
$371K Sell
20,093
-490
-2% -$10K ﹤0.01% 2847
2024
Q2
$443K Buy
20,583
+537
+3% +$12.3K ﹤0.01% 2702
2024
Q1
$540K Buy
20,046
+709
+4% +$20.1K ﹤0.01% 2565
2023
Q4
$580K Sell
19,337
-4,213
-18% -$93K ﹤0.01% 2481
2023
Q3
$483K Buy
23,550
+2,034
+9% +$37K ﹤0.01% 2509
2023
Q2
$428K Buy
21,516
+2,436
+13% +$49.2K ﹤0.01% 2609
2023
Q1
$327K Buy
19,080
+2,548
+15% +$49.9K ﹤0.01% 2754
2022
Q4
$324K Buy
16,532
+2,571
+18% +$47.3K ﹤0.01% 2704
2022
Q3
$223K Buy
+13,961
New +$218K ﹤0.01% 2890

Other funds holding RCKT